Ra Pharmaceuticals
1 follower
‌
Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.
Industries
Headquarters
Employees
Links
Org chart
Douglas Treco
President and Chief Executive Officer, and Co-Founder
Douglas Treco
Collapse
Alonso Ricardo
Chief Technology and Innovation Officer and Head of Research
David Lubner
Executive Vice President and Chief Financial Officer
Joe Shulman
Senior Vice President, Technical Operations
John C. King
Chief Commercial Officer
Peter DiRoma
Senior Vice President, Regulatory, Quality, and Government Affairs
Petra Duda
Executive Director Clinical Research
Dan Parker
Research Technician
Wenqing Xu
Scientist
